| Product | Strength | Dosage Form | Therapeutic Category |
|---|---|---|---|
| Abiraterone | 250 mg | Tablets | Antineoplastics |
| Everolimus | 5 mg, 10 mg | Tablets | Antineoplastics |
| Deferasirox | 100, 250, 400, 500 mg | DT | Iron Chelating Agent |
| Aprepitant | 80 mg + 125 mg | Capsules | Antineoplastics |
| Product | Strength | Dosage Form | Therapeutic Category |
|---|---|---|---|
| Abiraterone | 250 mg | Tablets | Antineoplastics |
| Everolimus | 5 mg, 10 mg | Tablets | Antineoplastics |
| Deferasirox | 100, 250, 400, 500 mg | DT | Iron Chelating Agent |
| Aprepitant | 80 mg + 125 mg | Capsules | Antineoplastics |